5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases
- PMID: 23950017
- DOI: 10.1002/ajmg.a.36108
5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases
Abstract
The 5q31.3 microdeletion syndrome has recently emerged as a distinct clinical entity, and we report two new patients with de novo deletions of this region, bringing the total to seven. Similarly to previously reported cases, the phenotype of our patients is characterized by marked hypotonia, apnea, developmental delay, and feeding difficulties. Both patients had abnormal movements which did not correlate with epileptiform activity on electroencephalogram (EEG). Developmental brain changes on neuroimaging consisted of abnormalities predominantly affecting the white matter and frontal lobes. The 5q31.3 deleted regions overlap those of previously reported cases, and allow further refinement of the shortest region of overlap to 101 kb, including only three genes. Of these, the purine-rich element binding protein A (PURA) gene has an established role in brain development, and we propose that haploinsufficiency for this gene is primarily responsible for the neurodevelopmental features observed.
Keywords: 5q31.3 microdeletion syndrome; neonatal hypotonia; purine-rich element-binding protein A (PURA).
Copyright © 2013 Wiley Periodicals, Inc.
Similar articles
-
A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.Eur J Hum Genet. 2023 Jan;31(1):112-121. doi: 10.1038/s41431-022-01217-4. Epub 2022 Nov 14. Eur J Hum Genet. 2023. PMID: 36376392 Free PMC article.
-
Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome.Am J Med Genet A. 2012 Aug;158A(8):1891-6. doi: 10.1002/ajmg.a.35439. Epub 2012 Jun 18. Am J Med Genet A. 2012. PMID: 22711443
-
Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA.Mol Cytogenet. 2015 Nov 14;8:89. doi: 10.1186/s13039-015-0193-9. eCollection 2015. Mol Cytogenet. 2015. PMID: 26582469 Free PMC article.
-
Differences in manifestations of epilepsy and developmental delay in PURA syndrome and 5q31 microdeletions.Clin Genet. 2024 Oct;106(4):386-393. doi: 10.1111/cge.14581. Epub 2024 Jun 24. Clin Genet. 2024. PMID: 38923490 Review.
-
Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures.Am J Med Genet A. 2014 Feb;164A(2):441-8. doi: 10.1002/ajmg.a.36320. Epub 2013 Dec 19. Am J Med Genet A. 2014. PMID: 24357076 Review.
Cited by
-
A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.Eur J Hum Genet. 2023 Jan;31(1):112-121. doi: 10.1038/s41431-022-01217-4. Epub 2022 Nov 14. Eur J Hum Genet. 2023. PMID: 36376392 Free PMC article.
-
De novo mutations in PURA are associated with hypotonia and developmental delay.Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000356. doi: 10.1101/mcs.a000356. Cold Spring Harb Mol Case Stud. 2015. PMID: 27148565 Free PMC article.
-
Lessons learned from additional research analyses of unsolved clinical exome cases.Genome Med. 2017 Mar 21;9(1):26. doi: 10.1186/s13073-017-0412-6. Genome Med. 2017. PMID: 28327206 Free PMC article.
-
Case Report: Expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo.Front Pediatr. 2024 Mar 28;12:1323014. doi: 10.3389/fped.2024.1323014. eCollection 2024. Front Pediatr. 2024. PMID: 38606370 Free PMC article.
-
PURA-Related Developmental and Epileptic Encephalopathy: Phenotypic and Genotypic Spectrum.Neurol Genet. 2021 Nov 15;7(6):e613. doi: 10.1212/NXG.0000000000000613. eCollection 2021 Dec. Neurol Genet. 2021. PMID: 34790866 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases